Cibus (NASDAQ:CBUS – Get Free Report) will post its quarterly earnings results after the market closes on Thursday, May 9th. Analysts expect Cibus to post earnings of ($1.01) per share for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.
Cibus (NASDAQ:CBUS – Get Free Report) last posted its quarterly earnings results on Thursday, March 21st. The company reported ($1.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.12) by ($0.04). Cibus had a negative return on equity of 22.70% and a negative net margin of 14,729.06%. The firm had revenue of $1.10 million for the quarter, compared to analysts’ expectations of $0.27 million. On average, analysts expect Cibus to post $-3 EPS for the current fiscal year and $-2 EPS for the next fiscal year.
Cibus Stock Up 3.6 %
Shares of CBUS opened at $17.68 on Tuesday. The stock’s 50 day moving average is $18.52 and its two-hundred day moving average is $16.62. Cibus has a twelve month low of $8.90 and a twelve month high of $38.85.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Analysis on Cibus
Cibus Company Profile
Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.
Featured Articles
- Five stocks we like better than Cibus
- What is the Dogs of the Dow Strategy? Overview and Examples
- Lemonade Squeezes as Breakeven Date Gets Pulled Closer
- How to Invest in Insurance Companies: A Guide
- Tech Earnings Insights: Where Opportunity Meets Uncertainty
- The Most Important Warren Buffett Stock for Investors: His Own
- 3 CEO-Led Turnaround Stocks You Can Still Buy
Receive News & Ratings for Cibus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cibus and related companies with MarketBeat.com's FREE daily email newsletter.